• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年垂体腺瘤诊断和管理的共识指南:第 1 部分,一般建议。

Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.

机构信息

Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Alder Hey Children's Hospital, Liverpool, UK.

出版信息

Nat Rev Endocrinol. 2024 May;20(5):278-289. doi: 10.1038/s41574-023-00948-8. Epub 2024 Feb 9.

DOI:10.1038/s41574-023-00948-8
PMID:38336897
Abstract

Tumours of the anterior part of the pituitary gland represent just 1% of all childhood (aged <15 years) intracranial neoplasms, yet they can confer high morbidity and little evidence and guidance is in place for their management. Between 2014 and 2022, a multidisciplinary expert group systematically developed the first comprehensive clinical practice consensus guideline for children and young people under the age 19 years (hereafter referred to as CYP) presenting with a suspected pituitary adenoma to inform specialist care and improve health outcomes. Through robust literature searches and a Delphi consensus exercise with an international Delphi consensus panel of experts, the available scientific evidence and expert opinions were consolidated into 74 recommendations. Part 1 of this consensus guideline includes 17 pragmatic management recommendations related to clinical care, neuroimaging, visual assessment, histopathology, genetics, pituitary surgery and radiotherapy. While in many aspects the care for CYP is similar to that of adults, key differences exist, particularly in aetiology and presentation. CYP with suspected pituitary adenomas require careful clinical examination, appropriate hormonal work-up, dedicated pituitary imaging and visual assessment. Consideration should be given to the potential for syndromic disease and genetic assessment. Multidisciplinary discussion at both the local and national levels can be key for management. Surgery should be performed in specialist centres. The collection of outcome data on novel modalities of medical treatment, surgical intervention and radiotherapy is essential for optimal future treatment.

摘要

垂体前叶肿瘤占所有儿童(<15 岁)颅内肿瘤的 1%,但它们可导致高发病率,且目前针对其治疗的证据和指导很少。2014 年至 2022 年间,一个多学科专家小组系统地为 19 岁以下(以下简称 CYP)疑似垂体腺瘤的儿童和年轻人制定了首个全面的临床实践共识指南,以提供专业护理并改善健康结果。通过强有力的文献检索和国际专家德尔菲共识小组的德尔菲共识实践,将现有的科学证据和专家意见整合为 74 条建议。本共识指南的第 1 部分包括 17 条与临床护理、神经影像学、视觉评估、组织病理学、遗传学、垂体手术和放射治疗相关的实用管理建议。虽然 CYP 的护理在许多方面与成人相似,但存在关键差异,特别是在病因和表现方面。疑似垂体腺瘤的 CYP 需要仔细的临床检查、适当的激素检查、专门的垂体成像和视觉评估。应考虑潜在的综合征疾病和遗传评估。在地方和国家各级进行多学科讨论对于管理至关重要。手术应在专业中心进行。收集新型药物治疗、手术干预和放射治疗的结果数据对于未来的最佳治疗至关重要。

相似文献

1
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.儿童和青少年垂体腺瘤诊断和管理的共识指南:第 1 部分,一般建议。
Nat Rev Endocrinol. 2024 May;20(5):278-289. doi: 10.1038/s41574-023-00948-8. Epub 2024 Feb 9.
2
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases.儿童和青少年垂体腺瘤的诊断和管理共识指南:第 2 部分,特定疾病。
Nat Rev Endocrinol. 2024 May;20(5):290-309. doi: 10.1038/s41574-023-00949-7. Epub 2024 Feb 9.
3
Pituitary adenomas: current methods of diagnosis and treatment.垂体腺瘤:当前的诊断与治疗方法
Oncology (Williston Park). 1997 Jun;11(6):791-6; discussion 798, 803-4.
4
Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.儿童垂体肿瘤:诊断、治疗及分子遗传学的最新进展
Expert Rev Neurother. 2008 Apr;8(4):563-74. doi: 10.1586/14737175.8.4.563.
5
Clinically nonsecreting pituitary adenomas in childhood and adolescence.儿童及青少年期临床无分泌功能的垂体腺瘤。
Neurosurgery. 1998 Apr;42(4):744-50; discussion 750-1. doi: 10.1097/00006123-199804000-00037.
6
Update on the Genetics of Pituitary Tumors.垂体瘤遗传学研究进展。
Endocrinol Metab Clin North Am. 2020 Sep;49(3):433-452. doi: 10.1016/j.ecl.2020.05.005.
7
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.垂体学会德尔菲调查:经蝶窦手术治疗垂体腺瘤患者内分泌管理的国际视角。
Pituitary. 2022 Feb;25(1):64-73. doi: 10.1007/s11102-021-01170-3. Epub 2021 Jul 20.
8
[Strengthen the multidisciplinary treatments to improve the clinical outcome of pituitary adenoma].加强多学科治疗以改善垂体腺瘤的临床疗效
Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 May;44(3):436-40.
9
Biological and radiological exploration and management of non-functioning pituitary adenoma.无功能垂体腺瘤的生物学与放射学探索及管理
Ann Endocrinol (Paris). 2015 Jul;76(3):201-9. doi: 10.1016/j.ando.2015.04.005. Epub 2015 Jun 26.
10
Current Status of Diagnosis and Management for Functioning Pituitary Tumors: Part I.功能性垂体瘤的诊断与治疗现状:第一部分。
Neurol India. 2020 May-Jun;68(Supplement):S13-S19. doi: 10.4103/0028-3886.287680.

引用本文的文献

1
Insights into (rs351855 and rs7708357) Gene Variants, Ki-67 and p53 in Pituitary Adenoma Pathophysiology.垂体腺瘤病理生理学中(rs351855和rs7708357)基因变异、Ki-67和p53的研究进展
Int J Mol Sci. 2025 Aug 5;26(15):7565. doi: 10.3390/ijms26157565.
2
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.垂体偶发瘤:一项垂体协会国际共识指南声明
Nat Rev Endocrinol. 2025 Jun 24. doi: 10.1038/s41574-025-01134-8.
3
Pediatric Pituitary Adenomas and Cysts: A 46-Year Population-Based Analysis.小儿垂体腺瘤和囊肿:一项基于人群的46年分析

本文引用的文献

1
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.垂体腺瘤或神经内分泌肿瘤:综合预后分类的必要性。
Nat Rev Endocrinol. 2023 Nov;19(11):671-678. doi: 10.1038/s41574-023-00883-8. Epub 2023 Aug 17.
2
National UK guidelines for the management of paediatric craniopharyngioma.英国国家指南:儿童颅咽管瘤的管理
Lancet Diabetes Endocrinol. 2023 Sep;11(9):694-706. doi: 10.1016/S2213-8587(23)00162-6. Epub 2023 Aug 4.
3
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
J Endocr Soc. 2025 Apr 24;9(6):bvaf069. doi: 10.1210/jendso/bvaf069. eCollection 2025 Jun.
4
Germline genetic variants in young-onset sporadic pituitary macroadenomas: A multigene panel analysis.年轻散发性垂体大腺瘤中的胚系基因变异:多基因panel分析
J Clin Transl Endocrinol. 2025 Apr 4;40:100389. doi: 10.1016/j.jcte.2025.100389. eCollection 2025 Jun.
5
Association of pituitary neuroendocrine tumors and neurofibromatosis type 1: assessing causation versus coincidence. Case report.垂体神经内分泌肿瘤与1型神经纤维瘤病的关联:评估因果关系与巧合。病例报告。
Front Endocrinol (Lausanne). 2025 Feb 4;16:1483305. doi: 10.3389/fendo.2025.1483305. eCollection 2025.
6
Pituitary Neuroendocrine Tumors in Multiple Endocrine Neoplasia.多发性内分泌腺瘤病中的垂体神经内分泌肿瘤
Endocrinol Metab (Seoul). 2025 Feb;40(1):39-46. doi: 10.3803/EnM.2024.2074. Epub 2024 Aug 30.
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
4
Paediatric Pituitary Adenomas: Clinical Presentation, Biochemical Profile and Long-Term Prognosis.儿童垂体腺瘤:临床表现、生化特征及长期预后。
Neurol India. 2022 Jan-Feb;70(1):304-311. doi: 10.4103/0028-3886.338667.
5
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.重复序列破坏染色质结构,并重新连接 X 连锁肢端巨大症中的 GPR101 增强子通讯。
Am J Hum Genet. 2022 Apr 7;109(4):553-570. doi: 10.1016/j.ajhg.2022.02.002. Epub 2022 Feb 23.
6
Pediatric pituitary adenomas are more aggressive, more likely to be hormone producing and are more difficult to cure than adult pituitary adenomas: case series and systematic literature review.小儿垂体腺瘤比成人垂体腺瘤更具侵袭性,更有可能产生激素,且更难治愈:病例系列和系统文献回顾。
Childs Nerv Syst. 2022 Apr;38(4):729-738. doi: 10.1007/s00381-022-05445-3. Epub 2022 Jan 19.
7
Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas.利用分子影像学增强垂体腺瘤管理中的决策制定。
J Nucl Med. 2021 Jul;62(Suppl 2):57S-62S. doi: 10.2967/jnumed.120.251546.
8
Positive [F]fluoroethyltyrosine PET/MRI in suspected recurrence of growth hormone-producing pituitary adenoma in a paediatric patient.正电子发射断层显像/磁共振成像(PET/MRI)检查发现儿科患者生长激素分泌型垂体腺瘤疑似复发。
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):410-411. doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 5.
9
Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline.特发性垂体柄增厚、中枢性尿崩症或两者并存的儿童和青少年的管理:国家临床实践共识指南。
Lancet Child Adolesc Health. 2021 Sep;5(9):662-676. doi: 10.1016/S2352-4642(21)00088-2. Epub 2021 Jun 30.
10
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis.术中磁共振成像对垂体手术全切除、切除范围和残余肿瘤体积的影响:系统评价和荟萃分析。
Pituitary. 2021 Aug;24(4):644-656. doi: 10.1007/s11102-021-01147-2. Epub 2021 May 4.